Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.
Arehart E, Stitham J, Asselbergs FW, Douville K, MacKenzie T, Fetalvero KM, Gleim S, Kasza Z, Rao Y, Martel L, Segel S, Robb J, Kaplan A, Simons M, Powell RJ, Moore JH, Rimm EB, Martin KA, Hwa J.
Arehart E, et al. Among authors: moore jh.
Circ Res. 2008 Apr 25;102(8):986-93. doi: 10.1161/CIRCRESAHA.107.165936. Epub 2008 Mar 6.
Circ Res. 2008.
PMID: 18323528
Free PMC article.